Contact us for free information or to start a free case review.
After COX-2 painkillers – Vioxx, Celebrex and Bextra- came under scrutiny when cardiovascular risks were associated to the drugs some drugmakers saw this as an opportunity to try to capitalize on the events.
Vioxx went off the market in September 2004, and though Celebrex and Bextra remained on the market, the cardiovascular Vioxx events were believed to be a class wide effect. In the week that Vioxx went off the market Boehringer Ingelheim, the maker of pain reliever Mobic, ran consumer ads suggesting patients talk to doctors about alternatives like Mobic.
The company called the consumer ads rare, but it seems to have paid off. Mobic accounted for 4.4 percent of new arthritis painkillers in the week Vioxx was recalled, which increased to eight percent in the week that ended March 11. Mobic’s share of new arthritis prescriptions rose as high as 9.4 percent in February before an FDA scientist, David Graham, told an FDA advisory panel that Mobic might have the same safety risks as COX-2 drugs.
The FDA advisory panel recommended Celebrex and Bextra remain on the market despite the cardiovascular risks. Although the panel believed Celebrex and Bextra benefits outweighed the risks, experts have recommended alternative medications be considered first, including ibuprofen, naproxen or aspirin.
All patients will have individual risk factors that must be weighed prior to deciding on any one therapy.
Copyright © 2001 - 2012 Online Lawyer Source
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.